Glaxosmithkline Plc
- All
- News
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
All 37 Omicron Mutations Defeated By This New Antibody Treatment
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant.
-
Sanofi, GlaxoSmithKline Get India's Approval For Late-Stage Vaccine Trial
Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.
-
French Drugmaker Sanofi Expects Approval Of COVID-19 Vaccine By Next Year
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
-
Government's Plan To Pull In 324 Companies Including Tesla, Glaxo: Report
The government is planning to offer 324 companies including Tesla Inc. and GlaxoSmithKline Plc incentives to set up factories in India in a bid to capitalize from the trade war between China and the US., according to a document seen by Bloomberg.
-
UK Competition Authorities Fine GlaxoSmithKline $54.5 Million
Britain's competition authority has fined drug maker GlaxoSmithKline plc 37.6 million pounds ($54.5 million) for stalling the potential entry of generic competitors of an anti-depressant drug Seroxat into the marketplace.
-
You Probably Have Herpes: WHO
Two-thirds of the world's population under 50 have the highly infectious herpes virus that causes cold sores around the mouth, the World Health Organization said on Wednesday, in its first estimate of global prevalence of the disease.
-
US Emergency Labs Ready to Work on Ebola Drugs if Asked
All three US facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any U.S. government effort to scale up a treatment for Ebola.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
All 37 Omicron Mutations Defeated By This New Antibody Treatment
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant.
-
Sanofi, GlaxoSmithKline Get India's Approval For Late-Stage Vaccine Trial
Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.
-
French Drugmaker Sanofi Expects Approval Of COVID-19 Vaccine By Next Year
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
-
Government's Plan To Pull In 324 Companies Including Tesla, Glaxo: Report
The government is planning to offer 324 companies including Tesla Inc. and GlaxoSmithKline Plc incentives to set up factories in India in a bid to capitalize from the trade war between China and the US., according to a document seen by Bloomberg.
-
UK Competition Authorities Fine GlaxoSmithKline $54.5 Million
Britain's competition authority has fined drug maker GlaxoSmithKline plc 37.6 million pounds ($54.5 million) for stalling the potential entry of generic competitors of an anti-depressant drug Seroxat into the marketplace.
-
You Probably Have Herpes: WHO
Two-thirds of the world's population under 50 have the highly infectious herpes virus that causes cold sores around the mouth, the World Health Organization said on Wednesday, in its first estimate of global prevalence of the disease.
-
US Emergency Labs Ready to Work on Ebola Drugs if Asked
All three US facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any U.S. government effort to scale up a treatment for Ebola.
